CAL
AGN

Capital Analysts LLC’s Allergan plc AGN Stock Holding History

Capital Analysts LLC’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-130
Closed -$23K – 733
2020
Q1 		$23K Hold
130
– – ﹤0.01% 435
2019
Q4 		$25K Hold
130
– – ﹤0.01% 474
2019
Q3 		$21K Hold
130
– – ﹤0.01% 471
2019
Q2 		$22K Sell
130
-340
-72% -$47.1K ﹤0.01% 452
2019
Q1 		$68K Buy
470
+139
+42% +$20.2K 0.01% 311
2018
Q4 		$44K Sell
331
-654
-66% -$107K 0.01% 336
2018
Q3 		$188K Buy
985
+40
+4% +$7.35K 0.02% 199
2018
Q2 		$158K Buy
945
+60
+7% +$9.63K 0.02% 208
2018
Q1 		$149K Buy
885
+280
+46% +$47K 0.02% 205
2017
Q4 		$99K Sell
605
-1,190
-66% -$214K 0.01% 241
2017
Q3 		$368K Hold
1,795
– – 0.05% 161
2017
Q2 		$436K Hold
1,795
– – 0.06% 160
2017
Q1 		$429K Sell
1,795
-454
-20% -$106K 0.07% 150
2016
Q4 		$472K Sell
2,249
-10,534
-82% -$2.18M 0.08% 154
2016
Q3 		$2.94M Sell
12,783
-368
-3% -$89.9K 0.55% 37
2016
Q2 		$3.04M Buy
13,151
+11,786
+863% +$2.72M 0.61% 37
2016
Q1 		$366K Buy
1,365
+965
+241% +$276K 0.07% 154
2015
Q4 		$125K Sell
400
-350
-47% -$104K 0.03% 196
2015
Q3 		$204K Buy
750
+475
+173% +$146K 0.04% 183
2015
Q2 		$83.5K Hold
275
– – 0.02% 225
2015
Q1 		$81.8K Buy
275
+40
+17% +$11.4K 0.02% 219
2014
Q4 		$60.5K Buy
235
+135
+135% +$33.7K 0.01% 237
2014
Q3 		$24.1K Hold
100
– – 0.01% 303
2014
Q2 		$22.3K Buy
+100
New +$20.7K 0.01% 299

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Capital Analysts LLC's AGN Position: Q2 2020 in Review

Capital Analysts LLC sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 130 shares — an estimated $23K sold.

Capital Analysts LLC first reported a position in AGN in Q2 2014 and held it in 24 quarters. The position peaked at $3.04M in Q2 2016. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Capital Analysts LLC reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Capital Analysts LLC sold 130 Allergan plc shares in Q2 2020, an estimated $23K.
  • Capital Analysts LLC first reported a position in Allergan plc in Q2 2014 and held it in 24 quarters.
  • Capital Analysts LLC's Allergan plc position peaked at $3.04M in Q2 2016.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Capital Analysts LLC's 13F filing for Q2 2020, filed 7 Aug 2020.